Top compounds associated with response to USP17L29


Feature Type Standardized
Nominal ANOVA
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.029 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA PDMP CTRPv2 pan-cancer AAC -0.028 0.5
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.025 0.5
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.023 0.5
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.04 0.5
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.027 0.5
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.5
Download CSV